Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Vaccines01:30

Cancer Vaccines

367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Assessing the Estimands and Estimates of Hospitalization Rates in Health Economics and Clinical Medicine.

Health economics·2026
Same author

What is the general Welfare: Welfare economic perspectives on equity.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Erratum: Using Limited Trial Evidence to Credibly Choose Treatment Dosage when Efficacy and Adverse Effects Weakly Increase with Dose.

Epidemiology (Cambridge, Mass.)·2025
Same author

Novel approaches to optimization of drug dosages.

Clinical advances in hematology & oncology : H&O·2025
Same author

Comparing the cost of cirrhosis to other common chronic diseases: A longitudinal study in a large national insurance database.

Hepatology (Baltimore, Md.)·2025
Same author

Using Limited Trial Evidence to Credibly Choose Treatment Dosage when Efficacy and Adverse Effects Weakly Increase with Dose.

Epidemiology (Cambridge, Mass.)·2024

相关实验视频

Updated: Jul 4, 2025

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.8K

在免疫疗法方案中的不确定性导航

Charles F Manski1

  • 1Department of Economics and Institute for Policy Research, Northwestern University, Evanston, IL.

NEJM evidence
|February 6, 2024
PubMed
概括

导航免疫疗法方案为患者带来了重大不确定性. 这一观点强调了需要改进的证据和方法来指导临床决策和增强患者护理的需要.

科学领域:

  • 在瘤学瘤学.
  • 临床决策 - 临床决策
  • 医疗保健服务研究 医疗服务研究

背景情况:

  • 免疫疗法彻底改变了癌症治疗,为患者提供了新的希望.
  • 然而,由于复杂的治疗方案和患者反应的变化,治疗选择和管理涉及相当大的不确定性.
  • 患者经常在理解和应对这些治疗不确定性方面面临挑战.

研究的目的:

  • 分享患者在免疫治疗中的不确定性生活经验.
  • 讨论关于改善患者护理的证据和方法的学术观点.
  • 弥合临床挑战与旨在改善患者结果的研究之间的差距.

主要方法:

  • 来自患者和学者的个人叙述.
  • 对临床经验和研究工作的反思.
  • 讨论基于证据的实践和决策.

主要成果:

  • 摘要不包含具体的结果,但提供了导航不确定性的观点.
  • 强调患者和研究人员在理解治疗挑战方面的双重作用.
  • 强调需要在临床实践中增强数据和方法.

结论:

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

363
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.1K

相关实验视频

Last Updated: Jul 4, 2025

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.8K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

363
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.1K
  • 改进的证据和研究方法对于解决免疫治疗中的不确定性至关重要.
  • 患者的观点对于塑造研究和临床实践至关重要.
  • 以患者为中心的方法可以更好地导航复杂的癌症治疗方案.